日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemical inhibition of INO1 reduces phytic acid in rice and wheat grains for enhanced micronutrient bioavailability

化学抑制INO1可降低水稻和小麦籽粒中的植酸含量,从而提高微量营养素的生物利用度。

Akabane, Tatsuki; Kamino, Satoshi; Okamura, Tomoki; Sugaya, Atomu; Nakamura, Momona; Ikeda, Kazuyoshi; Yonezawa, Tomoki; Fukushima, Ayaka; Kojima, Shota; Aoki, Yota; Chujo, Sakura; Yamauchi, Yusei; Shibusawa, Rioko; Ishimaru, Ken; Nagasaka, Seiji; Katoh, Etsuko; Hirotsu, Naoki

Engineering of genetically encoded programmable calcium channel inhibitory binders

基因编码可编程钙通道抑制剂结合剂的工程改造

Liu, Xiaoxuan; Ali, Sher; Lan, Tien-Hung; Wang, Decheng; McKee, Brendan; Nonomura, Tatsuki; Liu, Siyao; Zhao, Feng; Zhu, Michael X; Huang, Yun; Deng, Qing; Ma, Guolin; Zhou, Yubin

Presence or Emergence of Canine Leishmaniasis, Malawi

马拉维犬利什曼病的出现或爆发

Chikufenji, Boniface; Hayashida, Kyoko; Goto, Yasuyuki; Sugi, Tatsuki; Sanjoba, Chizu; Njala, Chrispin; McDermott, Inga; Lohr, Frederic; Mayer, Dagmar; Ogata, Shohei; Kajihara, Masahiro; Nao, Naganori; Nakao, Ryo; Chimaliro, Laston; Kapira, Donales; Musaya, Janelisa; Yamagishi, Junya; Chatanga, Elisha

Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study

乌司奴单抗、维多珠单抗和肿瘤坏死因子抑制剂在极早期发病炎症性肠病中的真实世界疗效:一项多中心队列研究

Nambu, Ryusuke; Iwama, Itaru; Takeuchi, Ichiro; Hagiwara, Shin-Ichiro; Etani, Yuri; Kaji, Emiri; Yoden, Atsushi; Kakuta, Fumihiko; Hoshi, Yusuke; Tsumura, Naoya; Mizuochi, Tatsuki; Kumagai, Hideki; Yokoyama, Koji; Nishizawa, Takuya; Usami, Masaaki; Takaki, Yugo; Ebana, Ryo; Kurasawa, Shingo; Fujikawa, Hiroki; Ishige, Takashi; Kudo, Takahiro; Yoshida, M Masashi; Shimizu, Hirotaka; Arai, Katsuhiro

Early Walnut Powder Introduction for Prevention of Walnut Sensitisation in High-Risk Infants With Eczema: An Open-Label, Randomised, Non-Inferiority Trial

早期引入核桃粉预防高危湿疹婴儿核桃过敏:一项开放标签、随机、非劣效性试验

Hamaguchi, Sayaka; Saito-Abe, Mayako; Shimada, Mami; Ogasawara, Hisako; Jimbo, Chisato; Yaguchi, Tomoki; Harama, Daisuke; Suzuki, Daichi; Umezawa, Kotaro; Hirai, Seiko; Toyokuni, Kenji; Natsume, Osamu; Yamaide, Fumiya; Motomura, Chikako; Fukuie, Tatsuki; Oyha, Yukihiro; Yamamoto-Hanada, Kiwako

Artificial thymic organoid culture generates functional iPSC-derived CD4+ invariant natural killer T cells

人工胸腺类器官培养可产生功能性iPSC衍生的CD4+不变自然杀伤T细胞

Shiina, Sara; Ueda, Tatsuki; Iriguchi, Shoichi; Uemura, Yasushi; Kaneko, Shin

Vitamin E Modulates Hepatic Extracellular Adenosine Signaling to Attenuate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

维生素E调节肝脏细胞外腺苷信号传导,从而减轻代谢功能障碍相关的脂肪肝疾病(MASLD)

Shan, Mengting; Apolinario, Magdeline E Carrasco; Tokumaru, Tomoko; Shikano, Kenshiro; Phurpa, Phurpa; Kato, Ami; Teranishi, Hitoshi; Kume, Shinichiro; Shimizu, Nobuyuki; Kurokawa, Tatsuki; Hikida, Takatoshi; Hanada, Toshikatsu; Li, Yulong; Hanada, Reiko

Microhydration Effects on Hemibonds in [H(2)O-X](+)-(H(2)O)(n) (X = O(2) and CS(2); n = 0-2): Infrared Spectroscopic Characterization toward Understanding Charge-Resonance Interactions in Aqueous Environments

微水合作用对[H(2)OX](+)-(H(2)O)(n) (X = O(2) 和 CS(2);n = 0-2)中半键的影响:红外光谱表征在理解水溶液环境中电荷共振相互作用中的应用

Hosoda, Tatsuki; Fujii, Asuka

Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology

为什么选择 Cemiplimab?在 PD-L1 超高表达和鳞状细胞癌的一线治疗中,Cemiplimab 开辟了独特的治疗领域

Ikeda, Satoshi; Araki, Keigo; Kitagawa, Mai; Makihara, Natsuno; Nagata, Yutaro; Fujii, Kazuki; Yoshida, Kiyori; Ikoma, Tatsuki; Nakahama, Kahori; Takeyasu, Yuki; Katsushima, Utae; Yamanaka, Yuta; Kurata, Takayasu

A maternal exon H splice-site variant leading to pseudohypoparathyroidism type 1B with broad methylation defects in GNAS-differentially methylated regions

母源外显子H剪接位点变异导致假性甲状旁腺功能减退症1B型,伴有GNAS差异甲基化区域的广泛甲基化缺陷

Urakawa, Tatsuki; Huang, Haipeng; Nagai, Takuhito; Hattori, Atsushi; Kawasaki, Tomoyuki; Saitsu, Hirotomo; Akutsu, Hidenori; Fukami, Maki; Kagami, Masayo